Skip to main content
Top
Published in: High Blood Pressure & Cardiovascular Prevention 5/2023

05-09-2023 | Heart Failure | Original article

Prognostic Clinical Phenotypes of Patients with Acute Decompensated Heart Failure

Authors: Tanya Mohammadi, Said Tofighi, Babak Mohammadi, Shadi Halimi, Farshad Gharebakhshi

Published in: High Blood Pressure & Cardiovascular Prevention | Issue 5/2023

Login to get access

Abstract

Introduction

Acute decompensated heart failure (AHF) is a clinical syndrome with a poor prognosis.

Aim

This study was conducted to identify clusters of inpatients with acute decompensated heart failure that shared similarities in their clinical features.

Methods

We analyzed data from a cohort of patients with acute decompensated heart failure hospitalized between February 2013 and January 2017 in a Department of Cardiology. Patients were clustered using factorial analysis of mixed data. The clusters (phenotypes) were then compared using log-rank tests and profiled using a logistic model. In total, 458 patients (255; 55.7% male) with a mean (SD) age of 72.7 (11.1) years were included in the analytic dataset. The demographic, clinical, and laboratory features were included in the cluster analysis.

Results

The two clusters were significantly different in terms of time to mortality and re-hospitalization (all P < 0.001). Cluster profiling yielded an accurate discriminating model (AUC = 0.934). Typically, high-risk patients were elderly females with a lower estimated glomerular filtration rate and hemoglobin on admission compared to the low-risk phenotype. Moreover, the high-risk phenotype had a higher likelihood of diabetes type 2, transient ischemic attack/cerebrovascular accident, previous heart failure or ischemic heart disease, and a higher serum potassium concentration on admission. Patients with the high-risk phenotype were of higher New York Heart Association functional classes and more positive in their medication history.

Conclusions

There are two phenotypes among patients with decompensated heart failure, high-risk and low-risk for mortality and re-hospitalization. They can be distinguished by easy-to-measure patients’ characteristics.
Literature
4.
go back to reference Crisanti L, Valli G, Cennamo E, Capolino A, Fratini P, Cesaro C, Adducchio G, De Magistris A, Terlizzi F, Ruggieri MP, Mirante E, Savoriti C, Sukruang K, Valeriano V, Pugliese FR, Travaglino F, Di Somma S. Usefulness of high-sensitivity troponin I in risk stratification and final disposition of patients with acute heart failure in the emergency department: comparison between HFpEF vs. HFrEF. Medicina (Kaunas). 2022. https://doi.org/10.3390/medicina59010007.CrossRefPubMed Crisanti L, Valli G, Cennamo E, Capolino A, Fratini P, Cesaro C, Adducchio G, De Magistris A, Terlizzi F, Ruggieri MP, Mirante E, Savoriti C, Sukruang K, Valeriano V, Pugliese FR, Travaglino F, Di Somma S. Usefulness of high-sensitivity troponin I in risk stratification and final disposition of patients with acute heart failure in the emergency department: comparison between HFpEF vs. HFrEF. Medicina (Kaunas). 2022. https://​doi.​org/​10.​3390/​medicina59010007​.CrossRefPubMed
7.
go back to reference McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine SA, Group ESCSD. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726. https://doi.org/10.1093/eurheartj/ehab368.CrossRefPubMed McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine SA, Group ESCSD. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726. https://​doi.​org/​10.​1093/​eurheartj/​ehab368.CrossRefPubMed
12.
15.
go back to reference Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors/Task Force M, Document R. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975. https://doi.org/10.1002/ejhf.592.CrossRefPubMed Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors/Task Force M, Document R. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975. https://​doi.​org/​10.​1002/​ejhf.​592.CrossRefPubMed
17.
go back to reference Yamamoto E, Kato T, Yaku H, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Himura Y, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Kawato M, Seko Y, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kimura T. Sex differences in patients with acute decompensated heart failure in Japan: observation from the KCHF registry. ESC Heart Fail. 2020;7(5):2485–93. https://doi.org/10.1002/ehf2.12815.CrossRefPubMedPubMedCentral Yamamoto E, Kato T, Yaku H, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Himura Y, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Kawato M, Seko Y, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kimura T. Sex differences in patients with acute decompensated heart failure in Japan: observation from the KCHF registry. ESC Heart Fail. 2020;7(5):2485–93. https://​doi.​org/​10.​1002/​ehf2.​12815.CrossRefPubMedPubMedCentral
18.
go back to reference Vidan MT, Martin Sanchez FJ, Sanchez E, Ortiz FJ, Serra-Rexach JA, Martinez-Selles M, Bueno H. Most elderly patients hospitalized for heart failure lack the abilities needed to perform the tasks required for self-care: impact on outcomes. Eur J Heart Fail. 2019;21(11):1434–42. https://doi.org/10.1002/ejhf.1559.CrossRefPubMed Vidan MT, Martin Sanchez FJ, Sanchez E, Ortiz FJ, Serra-Rexach JA, Martinez-Selles M, Bueno H. Most elderly patients hospitalized for heart failure lack the abilities needed to perform the tasks required for self-care: impact on outcomes. Eur J Heart Fail. 2019;21(11):1434–42. https://​doi.​org/​10.​1002/​ejhf.​1559.CrossRefPubMed
20.
go back to reference Santas E, Palau P, Llacer P, de la Espriella R, Minana G, Nunez-Marin G, Lorenzo M, Heredia R, Sanchis J, Chorro FJ, Bayes-Genis A, Nunez J. Sex-related differences in mortality following admission for acute heart failure across the left ventricular ejection fraction spectrum. J Am Heart Assoc. 2022;11(1): e022404. https://doi.org/10.1161/JAHA.121.022404.CrossRefPubMed Santas E, Palau P, Llacer P, de la Espriella R, Minana G, Nunez-Marin G, Lorenzo M, Heredia R, Sanchis J, Chorro FJ, Bayes-Genis A, Nunez J. Sex-related differences in mortality following admission for acute heart failure across the left ventricular ejection fraction spectrum. J Am Heart Assoc. 2022;11(1): e022404. https://​doi.​org/​10.​1161/​JAHA.​121.​022404.CrossRefPubMed
22.
26.
go back to reference Tromp J, Ter Maaten JM, Damman K, O’Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, van der Wal MH, Jaarsma T, van Veldhuisen DJ, Hillege HL, Voors AA, van der Meer P. Serum potassium levels and outcome in acute heart failure (Data from the PROTECT and COACH Trials). Am J Cardiol. 2017;119(2):290–6. https://doi.org/10.1016/j.amjcard.2016.09.038.CrossRefPubMed Tromp J, Ter Maaten JM, Damman K, O’Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, van der Wal MH, Jaarsma T, van Veldhuisen DJ, Hillege HL, Voors AA, van der Meer P. Serum potassium levels and outcome in acute heart failure (Data from the PROTECT and COACH Trials). Am J Cardiol. 2017;119(2):290–6. https://​doi.​org/​10.​1016/​j.​amjcard.​2016.​09.​038.CrossRefPubMed
30.
go back to reference Kotecha D, Flather MD, Altman DG, Holmes J, Rosano G, Wikstrand J, Packer M, Coats AJS, Manzano L, Böhm M, van Veldhuisen DJ, Andersson B, Wedel H, von Lueder TG, Rigby AS, Hjalmarson Å, Kjekshus J, Cleland JGF. Heart rate and rhythm and the benefit of beta-blockers in patients with heart failure. J Am Coll Cardiol. 2017;69(24):2885–96. https://doi.org/10.1016/j.jacc.2017.04.001.CrossRefPubMed Kotecha D, Flather MD, Altman DG, Holmes J, Rosano G, Wikstrand J, Packer M, Coats AJS, Manzano L, Böhm M, van Veldhuisen DJ, Andersson B, Wedel H, von Lueder TG, Rigby AS, Hjalmarson Å, Kjekshus J, Cleland JGF. Heart rate and rhythm and the benefit of beta-blockers in patients with heart failure. J Am Coll Cardiol. 2017;69(24):2885–96. https://​doi.​org/​10.​1016/​j.​jacc.​2017.​04.​001.CrossRefPubMed
31.
go back to reference Castagno D, Skali H, Takeuchi M, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pfeffer MA, McMurray JJV, Solomon SD. Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure: Results From the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) Program. J Ame Coll Cardiol. 2012;59(20):1785–95. https://doi.org/10.1016/j.jacc.2011.12.044.CrossRef Castagno D, Skali H, Takeuchi M, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pfeffer MA, McMurray JJV, Solomon SD. Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure: Results From the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) Program. J Ame Coll Cardiol. 2012;59(20):1785–95. https://​doi.​org/​10.​1016/​j.​jacc.​2011.​12.​044.CrossRef
39.
go back to reference Muiesan ML, Salvetti M, Virdis A, Masi S, Casiglia E, Tikhonoff V, Barbagallo CM, Bombelli M, Cicero AFG, Cirillo M, Cirillo P, Desideri G, D’Eliak L, Ferri C, Galletti F, Gesualdo L, Giannattasio C, Iaccarino G, Mallamaci F, Maloberti A, Mazza A, Nazzaro P, Palatini P, Parati G, Pontremoli R, Rattazzi M, Rivasi G, Tocci G, Ungar A, Verdecchia P, Viazzi F, Volpe M, Grassi G, Borghi C. Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study. J Hypertens. 2021;39(1):62–9. https://doi.org/10.1097/hjh.0000000000002589.CrossRefPubMed Muiesan ML, Salvetti M, Virdis A, Masi S, Casiglia E, Tikhonoff V, Barbagallo CM, Bombelli M, Cicero AFG, Cirillo M, Cirillo P, Desideri G, D’Eliak L, Ferri C, Galletti F, Gesualdo L, Giannattasio C, Iaccarino G, Mallamaci F, Maloberti A, Mazza A, Nazzaro P, Palatini P, Parati G, Pontremoli R, Rattazzi M, Rivasi G, Tocci G, Ungar A, Verdecchia P, Viazzi F, Volpe M, Grassi G, Borghi C. Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study. J Hypertens. 2021;39(1):62–9. https://​doi.​org/​10.​1097/​hjh.​0000000000002589​.CrossRefPubMed
40.
go back to reference Rebora P, Centola M, Morici N, Sacco A, Occhino G, Viola G, Oreglia J, Castini D, Persampieri S, Sabatelli L, Ferrante G, Lucreziotti S, Carugo S, Valsecchi MG, Oliva F, Giannattasio C, Maloberti A. Uric acid associated with acute heart failure presentation in Acute Coronary Syndrome patients. Eur J Intern Med. 2022;99:30–7. https://doi.org/10.1016/j.ejim.2022.01.018.CrossRefPubMed Rebora P, Centola M, Morici N, Sacco A, Occhino G, Viola G, Oreglia J, Castini D, Persampieri S, Sabatelli L, Ferrante G, Lucreziotti S, Carugo S, Valsecchi MG, Oliva F, Giannattasio C, Maloberti A. Uric acid associated with acute heart failure presentation in Acute Coronary Syndrome patients. Eur J Intern Med. 2022;99:30–7. https://​doi.​org/​10.​1016/​j.​ejim.​2022.​01.​018.CrossRefPubMed
Metadata
Title
Prognostic Clinical Phenotypes of Patients with Acute Decompensated Heart Failure
Authors
Tanya Mohammadi
Said Tofighi
Babak Mohammadi
Shadi Halimi
Farshad Gharebakhshi
Publication date
05-09-2023
Publisher
Springer International Publishing
Keyword
Heart Failure
Published in
High Blood Pressure & Cardiovascular Prevention / Issue 5/2023
Print ISSN: 1120-9879
Electronic ISSN: 1179-1985
DOI
https://doi.org/10.1007/s40292-023-00598-x

Other articles of this Issue 5/2023

High Blood Pressure & Cardiovascular Prevention 5/2023 Go to the issue